证券简称: 南京银行 证券代码: 601009 编号: 2025-003 优先股简称：南银优 1 优先股代码：360019 南银优 2 360024 可转债简称：南银转债 可转债代码：113050 南京银行股份有限公司 关于可转债转股结果暨股份变动的公告 特别提示： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 一、南银转债发行上市概况 经中国证券监督管理委员会《关于核准南京银行股份有限公司公开发行可转 换公司债券的批复》（证监许可[2021]1582号）核准，南京银行股份有限公司（以 下简称"南京银行"或"本公司"）于2021年6月15日向社会公开发行人民币200 亿元的可转换公司债券（以下简称"可转债""南银转债"），每张面值人民币 100元，按面值发行，期限6年。 经上海证券交易所自律监管决定书[2021]285号文同意，本公司200亿元可转 1 累计转股情况：截至2025年3月31日，累计已有人民币9,524,480,000元南银转 债转为本公司A股普通股，累计转股数为1,067,974,781股，占南 ...

Group 1 - The fund is named "浦银安盛 CFETS 0-5 Year Central Enterprise Bond Index Fund" and is managed by浦银安盛基金管理有限公司 with 南京银行股份有限公司 as the custodian [2][4][12] - The fund aims to achieve total returns similar to the underlying index before fees, using a passive index investment strategy and sampling replication method [2][5] - The fund's performance benchmark is defined as the CFETS 0-5 Year Central Enterprise Bond Index return multiplied by 95% plus the after-tax bank demand deposit rate multiplied by 5% [2][5] Group 2 - As of the end of the reporting period, the total fund shares amounted to 988,582,456.51 [2][4] - The fund reported a net profit of 45,585,088.0 for the period, with a net value growth rate of 4.24% for the past year [6][12] - The fund's annual profit distribution included a cash distribution of 0.6500 per 10 shares for Class A and 0.6000 for Class C [12][12] Group 3 - The fund management company,浦银安盛基金管理有限公司, was established in August 2007 and is primarily engaged in fund raising, sales, asset management, and other licensed activities [12][13] - The company manages a total of 107 funds, including various types of equity and bond funds [13][14] - The fund management team includes experienced professionals with backgrounds in finance and investment management [19][21]

蜂巢丰裕债券型证券投资基金 基金管理人:蜂巢基金管理有限公司 基金托管人:南京银行股份有限公司 报告送出日期:2025 年 03 月 31 日 蜂巢丰裕债券型证券投资基金 2024 年年度报告 基金管理人的董事会及董事保证本报告所载资料不存在虚假记载、误导性陈述或重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带的法律责任。本年度报告已经三分 之二以上独立董事签字同意，并由董事长签发。 基金托管人南京银行股份有限公司根据本基金合同规定，于2025年03月21日复核了本报告 中的财务指标、净值表现、利润分配情况、财务会计报告、投资组合报告等内容，保证复核内 容不存在虚假记载、误导性陈述或者重大遗漏。 基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一定盈 利。 基金的过往业绩并不代表其未来表现。投资有风险，投资者在作出投资决策前应仔细阅读 本基金的招募说明书及其更新。 本报告中财务资料已经审计，毕马威华振会计师事务所（特殊普通合伙）为本基金出具了 标准无保留意见的审计报告，请投资者注意阅读。 本报告期自2024年01月01日起至2024年12月31日止。 第 1 页，共 57 ...

Group 1 - Nanjing Bank has received approval from the China Securities Regulatory Commission to sell open-end mutual funds [1] - Starting from April 1, 2025, investors can conduct account opening, subscription, and redemption of the specified open-end funds at Nanjing Bank branches [1] - Investors are advised to read the fund contracts, prospectuses, and related legal documents carefully to understand the risks involved [1] Group 2 - Hai Fu Tong Fund Management Co., Ltd. has committed to managing and utilizing fund assets with honesty and diligence, but does not guarantee profits or minimum returns [4] - The full annual report for 97 funds under Hai Fu Tong will be disclosed on March 31, 2025, on the company's website and the China Securities Regulatory Commission's fund electronic disclosure website [4] - Investors are encouraged to understand the risk-return characteristics of the funds and make prudent investment decisions [4]

Core Insights - Nanjing Bank has launched an innovative financial product called "R&D Pipeline Loan" in collaboration with the National University Biomedicine Regional Technology Transfer Center, aimed at supporting early-stage biopharmaceutical projects that struggle to secure traditional bank loans due to long R&D cycles and high costs [1][5] - The first loan of 5 million yuan was approved and disbursed within two weeks, demonstrating the efficiency of the bank's approval process and its commitment to facilitating the transformation of scientific achievements into tangible assets [1][3] Group 1 - The "R&D Pipeline Loan" is specifically designed for startup R&D enterprises within the biopharmaceutical sector, addressing their medium to long-term funding needs [1][3] - The loan incorporates a pipeline assessment mechanism to evaluate the market value and progress of ongoing projects, enhancing the likelihood of successful commercialization [3] - The initiative marks a significant step for Nanjing Bank in promoting innovation within the biopharmaceutical industry, with plans to continue exploring innovative financial service models to support technology transformation [5]

Core Viewpoint - The Chinese government emphasizes the importance of green finance in promoting low-carbon and green development, as outlined in the recent government work report and the guiding opinions from the State Council [1][2]. Group 1: Green Finance Development - Green finance plays a crucial role in directing funds towards green industries and supporting the transition of traditional industries under the "dual carbon" goals [2][3]. - As of the end of Q4 2024, the balance of green loans in both domestic and foreign currencies reached 36.6 trillion yuan, a year-on-year increase of 21.7%, significantly outpacing the growth of other loans [3]. Group 2: Financial Product Innovation - Transition finance is highlighted as an effective complement to green finance, facilitating the upgrade of high-carbon industries through financial support for technology and business model innovations [4][5]. - Banks are innovating financial products, such as transition loans, to support high-carbon industries in their shift towards low-carbon operations, with specific examples like the 10 million yuan transition loan issued to a shipbuilding company [5]. Group 3: Challenges and Risk Management - Despite the growth in green finance offerings, challenges remain, including difficulties in risk identification and management, information asymmetry, and insufficient internal capabilities within banks [7][8]. - Banks are encouraged to enhance their due diligence processes and collaborate with government and enterprises to establish a unified environmental information disclosure platform for better risk assessment [8].

Core Insights - Nanjing Bank's Changzhou branch has successfully issued the first "Lighthouse Guarantee V" product loan of 2 million yuan to a local technology company, marking a significant milestone in supporting regional economic development [1][2] Group 1: Product Launch and Details - The "Lighthouse Guarantee V" product is a specialized policy loan aimed at supporting the aerospace technology industry in Wujin District, with a maximum loan amount of 30 million yuan per client [2] - The loan is primarily processed on a credit basis, with the bank applying the Loan Prime Rate (LPR) of 3.1% per annum, and companies can benefit from a 1% interest subsidy provided by the Wujin District government [2] Group 2: Company Background - The recipient company, established in 2021 and located in Changzhou Science and Education City, focuses on the research and production of aviation-grade motors, with applications in military and civil aviation systems [1] - The company has received multiple rounds of investment from the Changzhou Science and Education City Industrial Fund and other firms, indicating strong growth potential [1]

重要内容提示： 履行的审议程序：无锡新宏泰电器科技股份有限公司（以下称"公司"） 于 2024 年 8 月 22 日召开了公司第六届董事会第四次会议、第六届监事会第三次 会议，审议通过了《关于使用暂时闲置自有资金进行现金管理的议案》，拟使用 最高额度不超过 4 亿元人民币的暂时闲置的自有资金进行现金管理，投资安全性 较高、流动性较强、风险较低、收益率相对稳定的理财产品，该 4 亿元额度可滚 动使用，自通过之日起一年内有效，公司董事会授权公司高管团队在额度内办理 具体操作事宜。该事项无须提交公司股东大会审议。 一、本次现金管理概述 （一）现金管理目的 证券代码：603016 证券简称：新宏泰 公告编号：2025-004 无锡新宏泰电器科技股份有限公司 关于使用部分闲置自有资金进行现金管理到期赎回 并继续现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 公司及子公司在确保不影响正常经营及风险可控的前提下，使用闲置自有资 金开展现金管理业务，提高资金使用效率，为公司股东谋取更多的投资回报。 （二）资金来源 本次现 ...

Investment Rating - The investment rating for Nanjing Bank is "Buy" [6][8]. Core Views - Nanjing Bank's revenue growth in 2024 exceeded expectations, with a year-on-year increase of 11.3%, which is 3.3 percentage points higher than the growth rate in the previous three quarters [2][3]. - The bank's net profit attributable to shareholders is expected to grow by 9.1% year-on-year in 2024, maintaining a similar growth rate as in the first three quarters [2][3]. - The bank's asset quality remains stable, with a non-performing loan ratio of 0.83% at the end of 2024, unchanged from the previous quarter [5]. Summary by Sections Revenue and Profitability - Nanjing Bank's revenue for 2024 is projected to be 50,272 million yuan, reflecting an 11.32% increase compared to 2023 [7]. - The net profit attributable to shareholders is expected to reach 20,177 million yuan in 2024, representing a 9.05% increase from 2023 [7]. Loan and Deposit Growth - The bank's loans and deposits both showed strong year-on-year growth in Q4 2024, with loans increasing by 14.3% and deposits by 9.3% [4]. - In Q4 2024, deposits contributed 74% of the net increase in total deposits for the year, driven by a reduction in deposit rates [4]. Asset Quality - The non-performing loan ratio remained stable at 0.83% at the end of 2024, while the provision coverage ratio was 335%, down 5 percentage points from the previous quarter [5]. Earnings Forecast and Valuation - Nanjing Bank's net profit is forecasted to grow by 9.1% in 2024, 9.2% in 2025, and 9.0% in 2026, with corresponding book values per share of 14.11, 15.84, and 17.35 yuan [6]. - The target price is set at 14.26 yuan per share, indicating a potential upside of 33% based on a price-to-book ratio of 0.90 for 2025 [6].

Financial Performance - Total revenue for 2024 reached RMB 50.271 billion, an increase of 11.32% compared to RMB 45.160 billion in the previous year[3] - Net profit attributable to shareholders was RMB 20.177 billion, reflecting a year-on-year growth of 9.05% from RMB 18.502 billion[3] - Basic earnings per share increased to RMB 1.83, an 8.93% rise from RMB 1.68[3] - The weighted average return on equity was 12.97%, a slight decrease of 0.15 percentage points from the previous year[3] Asset and Loan Growth - Total assets at the end of the reporting period amounted to RMB 2591.402 billion, representing a growth of 13.25% from RMB 2288.276 billion at the beginning of the period[5] - Total deposits increased to RMB 1496.172 billion, up 9.26% from the previous year[6] - Total loans reached RMB 1256.398 billion, marking a growth of 14.31% year-on-year[6] Loan Quality - The non-performing loan ratio improved to 0.83%, down from 0.90% in the previous year[5] - The provision coverage ratio decreased to 335.27%, down from 360.58%[5] Strategic Focus - The company emphasizes a focus on high-quality development and enhancing service to the real economy, particularly in the Yangtze River Delta region[6]